Asia Pacific Specialty PACS Market Size, Share & Industry Trends Analysis Report By Deployment Model, By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), By Country and Growth Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Specialty PACS Market
Market Report Description
The Asia Pacific Specialty PACS Market would witness market growth of 6.7% CAGR during the forecast period (2021-2027).
The PACS serves with the benefits that a patient can go through radiological investigation at one separate location but the images can be accessed by multiple physicians and radiologists from different locations. The PACS technology stores the pictures in the archive and from there, those images can be reviewed on a review station. Furthermore, the increase in medical imaging volumes, the growing awareness of early disease diagnosis and the advancement in specialty PACS are surging demand for specialty PACS technology.
The information collected by the help of PACS systems can be utilized to identify any kind of physiological & anatomical abnormalities. The digital access can be considered as the most updated version of medical imaging. By having the clinical reports and history of the patients’ health condition through the PACS systems, the prescription and the treatment errors can be eliminated, which can enhance the patients’ overall treatment.
Growing GDP, increased spending in the development of healthcare infrastructure by the private as well as government sector, rapid urbanization, and the thriving medical tourism industry also serve as an opportunity for market growth mainly in emerging economies like India and China. Also, the increased demand for PACS systems in the countries like Indonesia and Australia has opened new avenues for the companies' manufacturing PACS systems which would result in the market growth of the Asia Pacific region.
The China market dominated the Asia Pacific Specialty PACS Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $302.6 million by 2027. The Japan market is anticipated to grow a CAGR of 6.1% during (2021 - 2027). Additionally, The India market would experience a CAGR of 7.3% during (2021 - 2027).
Based on Deployment Model, the market is segmented into On premises and Cloud-based. Based on Type, the market is segmented into Radiology PACS, Orthopedics PACS, Oncology PACS, Pathology PACS, Ophthalmology PACS, Women’s health PACS, and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novarad Enterprise Healthcare Solutions, Escalon Medical Corp., IBM Corporation, Siemens AG, Canon, Inc., INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., McKesson Corporation, Carestream Health, Inc., and Topcon Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Deployment Model
- On premises
- Radiology PACS
- Orthopedics PACS
- Oncology PACS
- Pathology PACS
- Ophthalmology PACS
- Women’s health PACS
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- South Korea
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Novarad Enterprise Healthcare Solutions
- Escalon Medical Corp.
- IBM Corporation
- Siemens AG
- Canon, Inc.
- INFINITT Healthcare Co. Ltd.
- Koninklijke Philips N.V.
- McKesson Corporation
- Carestream Health, Inc.
- Topcon Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free